Arxx Therapeutics

Developer of monoclonal antibody for fibrotic disease

placeOslo, Oslo, Norway calendar_todayFounded 2019 groups2 employees language arxxtx.com

Registered entities

Investor mix

7 investors on record; lead investors include Rasmussengruppen, Investinor, Altitude, Sarsia Seed.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%
Coming soon